I am interested in neurodegenerative disorders, in particular Alzheimer's Disease. I work to understand the pathological mechanisms underlying neurodegenerative processes. I aim to search for the failure of synaptic repair and modify the unfolded protein response in the endoplasmic reticulum. The aim is to achieve a safe neuroprotective, disease modifying agent to slow down the progress of neurocognitive disorders. Electroconvulsive Therapy (ECT) and other forms of neuromodulation in psychiatry is my other area of clinical interest which include research on the low pulse amplitude (< 800 mA), ultra-brief pulse (<0.5 ms) unilateral (ECT) usage to minimise the cognitive side effects of ECT while retaining its efficacy. As well as, optimising titration schedules and algorithms of ECT dosing strategies, and understanding the mechanism of action of ECT, and the mechanism by which ECT causes adverse event in order to provide safe and effective targeted delivery of ECT.